We are trioctanoin CAS:538-23-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Synonyms：
1,2,3-Tricapryloylglycerol,1,2,3-Trioctanoylglycerol,Glycerol tricaprylate1,2,3-Tri-n-octanoylglycerol2,3-di(octanoyloxy)propyl octanoateRatooctanoic acid 2,3-bis-octanoyloxypropyl esterOctanoic acid, 1,2,3-propanetriyl esterGlycerol Tri-n-octanoateCaprylinglycerin tricaprylateGlycerol trioctanoateTricaprylinTri-n-octanoinMaceightTrioctanoylglycerolGlyceryl trioctanoateOctanoin,tricaprylic acid triglycerideglycerol tricaprylateTricaprilinTrioctanoin
molecular formula: C27H50O6
Molecular weight: 470.68200
Physical Properties:
Density: 0.956 g/mL at 20 °C(lit.)
Boiling point: 233 °C1 mm Hg(lit.)
Melting point: 9-10 °C
Flash point: 225 °C
Refractive index: n20/D 1.448
Specification:
| Items of Analysis |
Standard of Analysis |
Test Results |
| Appearance |
Pale yellow or reddish-yellow oily liquid |
Conform |
| Assay |
≥99.0% |
99.31% |
| Conclusion |
Conforms to Factory Standard |
Application:
Axona is a medical food marketed for the clinical dietary management of the impairment of metabolic processes associated with mild to moderate Alzheimer's disease. It is a proprietary formulation of fractionated coconut oil (caprylic triglyceride), a medium-chain triglyceride. Accera, Inc., the company that makes Axona, states that during digestion, caprylic triglyceride is broken down into ketones, which provide an alternative energy source for the brain. Its use is based on the idea that the brain's ability to use its normal energy source, glucose, is impaired in Alzheimer's disease. Axona was first sold in March 2009.
Axona has not been approved by the US Food and Drug Administration (FDA) as a drug to treat Alzheimer's and the efficacy of managing the health of Alzheimer's patients by use of this medical food has been questioned by experts in the field, including the Alzheimer's Association.
Package and Storage:
Storage conditions: 2-8ºC
Market News:UQUIFA is a manufacturer of APIs and intermediates for the pharmaceutical industry globally. The company has 3 manufacturing sites (2 in Spain and 1 in Mexico) with strict adherence to all regulatory norms. benz(d,e)anthracene manufacturer.Injectable drug devices such as pens and cartridges accounted for 45% of the company’s sales last year, followed by insulin products with 16%. 6-Amino-5-benzoyl-2-cyanomethyl-4-phenyl-3-pyridinecarbonitrile supplier.The Company intends to further develop candidates from Mindset Families 2-4 with the goal of selecting additional lead candidates in the near future. N-acetyl-N-(1-acetyl-4-phenylpyrazol-3-yl)acetamide producer.
